These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
262 related items for PubMed ID: 17933488
1. [Systemic treatments of the vasospasm]. Tavernier B, Decamps F, Vega E, Poidevin P, Verdin M, Riegel B. Ann Fr Anesth Reanim; 2007 Nov; 26(11):980-4. PubMed ID: 17933488 [Abstract] [Full Text] [Related]
2. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Schmid-Elsaesser R, Kunz M, Zausinger S, Prueckner S, Briegel J, Steiger HJ. Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884 [Abstract] [Full Text] [Related]
3. Role of intraarterial therapy for cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage. Weant KA, Ramsey CN, Cook AM. Pharmacotherapy; 2010 Apr; 30(4):405-17. PubMed ID: 20334460 [Abstract] [Full Text] [Related]
4. [Perspectives in the treatment of subarachnoid-hemorrhage-induced cerebral vasospasm]. Fandino J, Fathi AR, Graupner T, Jacob S, Landolt H. Neurocirugia (Astur); 2007 Feb; 18(1):16-27. PubMed ID: 17393042 [Abstract] [Full Text] [Related]
7. Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: an overview of pharmacologic management. Liu-Deryke X, Rhoney DH. Pharmacotherapy; 2006 Feb; 26(2):182-203. PubMed ID: 16466324 [Abstract] [Full Text] [Related]
8. Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series. Barth M, Capelle HH, Münch E, Thomé C, Fiedler F, Schmiedek P, Vajkoczy P. Acta Neurochir (Wien); 2007 Feb; 149(9):911-8; discussion 918. PubMed ID: 17700991 [Abstract] [Full Text] [Related]
9. [Protective measures against cerebral ischemia following subarachnoid hemorrhage: Part 1]. Romero Kräuchi O, Verger Bennasar AM. Rev Esp Anestesiol Reanim; 2011 Apr; 58(4):230-5. PubMed ID: 21608279 [Abstract] [Full Text] [Related]
13. Which H is the most important in triple-H therapy for cerebral vasospasm? Treggiari MM, Deem S. Curr Opin Crit Care; 2009 Apr; 15(2):83-6. PubMed ID: 19276798 [Abstract] [Full Text] [Related]
14. [Endovascular treatment of vasospasm following subarachnoid aneurysmal haemorrhage]. Abdennour L, Lejean L, Bonneville F, Boch AL, Puybasset L. Ann Fr Anesth Reanim; 2007 Nov; 26(11):985-9. PubMed ID: 17935940 [Abstract] [Full Text] [Related]
15. Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage. Keyrouz SG, Diringer MN. Crit Care; 2007 Nov; 11(4):220. PubMed ID: 17705883 [Abstract] [Full Text] [Related]
19. [Recommendations for the management of patients with aneurysmal subarachnoid hemorrhage]. Raabe A, Beck J, Berkefeld J, Deinsberger W, Meixensberger J, Schmiedek P, Seifert V, Steinmetz H, Unterberg A, Vajkoczy P, Werner C, Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin. Zentralbl Neurochir; 2005 May; 66(2):79-91. PubMed ID: 15846536 [Abstract] [Full Text] [Related]
20. A clinical review of cerebral vasospasm and delayed ischaemia following aneurysm rupture. Dorsch N. Acta Neurochir Suppl; 2011 May; 110(Pt 1):5-6. PubMed ID: 21116906 [Abstract] [Full Text] [Related] Page: [Next] [New Search]